VREX Varex Imaging Corporation
USHealthcareAs of 2026-07-08 16:00
Why VREX matters now
Varex Imaging Corporation (VREX) is a US stock in Healthcare. The latest InvestLog snapshot shows $10.76 with +1.03% on the session and $453.0M in market capitalization; recent performance reads 1-month +12.98% and YTD -9.61%.
The latest financial table shown here is Q2 2026, with revenue of $216.0M, net income of $-8.1M, and EPS of $-0.19. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -6.9%.
The latest indexable market news headline is "Wall Street Analysts Think VAREX IMAGING (VREX) Could Surge 61.6%: Read This Before Placing a Bet" from Zacks Investment Research.
Additional event context on this page matters because analyst consensus is Buy with a median target of $14.50; recent insider activity includes Merkley Jesse Don filing . These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
0.93
P/S
0.52
EV/EBITDA
-119.20
DCF Value
$13.62
FCF Yield
-6.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
33.6%
Operating Margin
-3.7%
Net Margin
-9.6%
ROE
-17.6%
ROA
-7.6%
ROIC
-3.4%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $216.0M | $-8.1M | $-0.19 |
| Q1 2026 | $209.6M | $2.3M | $0.05 |
| Q4 2025 | $228.9M | $12.2M | $0.29 |
| FY 2025 | $844.6M | $-70.3M | $-1.70 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$14.50
Target (Median)
$14.50
Target Range
$14.50 - $14.50
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
0.90
Varex Imaging Corporation (VREX) specializes in the development and production of X-ray imaging components. Its operations are divided into two primary divisions: Medical and Industrial. Within the Medical segment, Varex provides a comprehensive range of X-ray imaging components. These include essential hardware like X-ray tubes, digital detectors, and high-voltage connectors, alongside sophisticated software solutions for image processing, 3D reconstruction, and computer-aided diagnostics. The segment also supplies critical ancillary devices such as collimators, generators, and automatic exposure control mechanisms. These medical products serve a wide spectrum of applications, from general diagnostic imaging like radiography and fluoroscopy, to specialized areas such as mammography, computed tomography (CT), cardiac procedures, dental imaging, and surgical applications. They are also vital for radiation therapy, oncology, and advanced computer-aided detection systems. The Industrial segment focuses on providing X-ray technology for security and industrial inspection. Its offerings include Linatron X-ray accelerators, X-ray tubes, digital detectors, and high-voltage connectors. These components are crucial for diverse applications such as airport security scanning, cargo screening at border crossings, and nondestructive testing across various industries. Varex distributes its products through multiple channels, including direct sales to end-users, partnerships with imaging system Original Equipment Manufacturers (OEMs), independent service providers, and a network of distributors. With a significant global footprint, the company maintains operations across North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Established in 2016, Varex Imaging Corporation is headquartered in Salt Lake City, Utah.